94 related articles for article (PubMed ID: 22243288)
1. Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening.
Austin RM; Zhao C
Cytopathology; 2012 Feb; 23(1):6-12. PubMed ID: 22243288
[TBL] [Abstract][Full Text] [Related]
2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
3. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
8. Screening history in women with cervical cancer in a Danish population-based screening program.
Kirschner B; Poll S; Rygaard C; Wåhlin A; Junge J
Gynecol Oncol; 2011 Jan; 120(1):68-72. PubMed ID: 21035171
[TBL] [Abstract][Full Text] [Related]
9. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
[TBL] [Abstract][Full Text] [Related]
10. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
11. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
12. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
14. A clinician's guide to Pap smear interpretation.
Mashburn J; Scharbo-DeHaan M
Nurse Pract; 1997 Apr; 22(4):115-8, 124-7, 130 passim. PubMed ID: 9128882
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria.
Todorova I; Ganchev G; Shikova E
J Clin Pathol; 2010 Dec; 63(12):1121-3. PubMed ID: 20943820
[TBL] [Abstract][Full Text] [Related]
18. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
19. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
20. Results from a cervical cancer screening programme in Manitoba, Canada.
Choi NW; Nelson NA
IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
